D-1087-2014 Class II Terminated
FDA drug recall D-1087-2014 was initiated by Actavis Elizabeth LLC on November 6, 2013 and is designated Class II. Reason for recall: Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification. The recall status is terminated (terminated June 2, 2014). Affected quantity: 13,608 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- March 5, 2014
- Initiation Date
- November 6, 2013
- Termination Date
- June 2, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,608 bottles
Product Description
Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)
Reason for Recall
Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
Distribution Pattern
Nationwide
Code Information
lot 58468552 Exp. 05/15